Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 2, 2025
- Accession no.
- 0001106578-25-000036
- Filed
- Dec 2, 2025
- Trade date
- Dec 1-2, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.85M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,590 | $480.28F2 | −$763,645.2 | 2,540 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,390 | $482.28F3 | −$670,369.2 | 1,150 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −520 | $483.38 | −$251,357.6 | 630 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −500 | $484.68 | −$242,340 | 130 | Direct | |
| Dec 2, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −1,000 | $478.64 | −$478,640 | 3,130 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −500 | $480.14 | −$240,070 | 2,630 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −769 | $481.72F4 | −$370,442.68 | 1,861 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −1,731 | $482.95F5 | −$835,986.45 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 54,000 | Direct | |
| Dec 2, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 50,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $480.055 to $481.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $482.01 to $482.8375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $481.41 to $482.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $482.55 to $483.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.